Yarrow Bioscience, Inc. (YARW)
30.21
+1.36
(+4.71%)
USD |
NASDAQ |
Sep 04, 16:00
30.53
+0.32
(+1.06%)
Pre-Market: 20:00
Yarrow Bioscience SG&A Expense (TTM) : 10.57M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.57M |
| March 31, 2026 | 10.89M |
| December 31, 2025 | 11.08M |
| September 30, 2025 | 11.88M |
| June 30, 2025 | 12.14M |
| March 31, 2025 | 12.70M |
| December 31, 2024 | 13.19M |
| September 30, 2024 | 13.91M |
| June 30, 2024 | 13.97M |
| March 31, 2024 | 13.90M |
| December 31, 2023 | 13.38M |
| September 30, 2023 | 13.20M |
| June 30, 2023 | 14.12M |
| March 31, 2023 | 15.21M |
| December 31, 2022 | 16.39M |
| September 30, 2022 | 17.47M |
| June 30, 2022 | 18.50M |
| March 31, 2022 | 18.98M |
| December 31, 2021 | 20.30M |
| September 30, 2021 | 33.41M |
| Date | Value |
|---|---|
| June 30, 2021 | 48.19M |
| March 31, 2021 | 69.86M |
| December 31, 2020 | 89.54M |
| September 30, 2020 | 93.86M |
| June 30, 2020 | 84.84M |
| March 31, 2020 | 65.18M |
| December 31, 2019 | 45.11M |
| September 30, 2019 | 26.26M |
| June 30, 2019 | 18.55M |
| March 31, 2019 | 14.83M |
| December 31, 2018 | 12.19M |
| September 30, 2018 | 10.53M |
| June 30, 2018 | 8.729M |
| March 31, 2018 | 6.853M |
| December 31, 2017 | 5.168M |
| September 30, 2017 | 4.76M |
| June 30, 2017 | 4.37M |
| March 31, 2017 | 3.156M |
| December 31, 2016 | 2.144M |
| September 30, 2016 | 0.846M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Theriva Biologics, Inc. | 6.919M |
| Nkarta, Inc. | 32.74M |
| Unicycive Therapeutics, Inc. | 23.53M |
| OnKure Therapeutics, Inc. | 15.19M |